Autophagy 2014-01-01

Autophagy in osteoblasts is involved in mineralization and bone homeostasis.

Marie Nollet, Sabine Santucci-Darmanin, Véronique Breuil, Rasha Al-Sahlanee, Chantal Cros, Majlinda Topi, David Momier, Michel Samson, Sophie Pagnotta, Laurence Cailleteau, Séverine Battaglia, Delphine Farlay, Romain Dacquin, Nicolas Barois, Pierre Jurdic, Georges Boivin, Dominique Heymann, Frank Lafont, Shi Shou Lu, David W Dempster, Georges F Carle, Valérie Pierrefite-Carle

Index: Autophagy 10(11) , 1965-77, (2014)

Full Text: HTML

Abstract

Bone remodeling is a tightly controlled mechanism in which osteoblasts (OB), the cells responsible for bone formation, osteoclasts (OC), the cells specialized for bone resorption, and osteocytes, the multifunctional mechanosensing cells embedded in the bone matrix, are the main actors. Increased oxidative stress in OB, the cells producing and mineralizing bone matrix, has been associated with osteoporosis development but the role of autophagy in OB has not yet been addressed. This is the goal of the present study. We first show that the autophagic process is induced in OB during mineralization. Then, using knockdown of autophagy-essential genes and OB-specific autophagy-deficient mice, we demonstrate that autophagy deficiency reduces mineralization capacity. Moreover, our data suggest that autophagic vacuoles could be used as vehicles in OB to secrete apatite crystals. In addition, autophagy-deficient OB exhibit increased oxidative stress and secretion of the receptor activator of NFKB1 (TNFSF11/RANKL), favoring generation of OC, the cells specialized in bone resorption. In vivo, we observed a 50% reduction in trabecular bone mass in OB-specific autophagy-deficient mice. Taken together, our results show for the first time that autophagy in OB is involved both in the mineralization process and in bone homeostasis. These findings are of importance for mineralized tissues which extend from corals to vertebrates and uncover new therapeutic targets for calcified tissue-related metabolic pathologies.

Related Compounds

Structure Name/CAS No. Articles
3-(1-Naphthyl)-2,5-diphenyl-2H-tetrazol-3-ium Structure 3-(1-Naphthyl)-2,5-diphenyl-2H-tetrazol-3-ium
CAS:1719-71-7
Ethanol Structure Ethanol
CAS:64-17-5
sodium dodecyl sulfate Structure sodium dodecyl sulfate
CAS:151-21-3
Ascorbic acid Structure Ascorbic acid
CAS:50-81-7
Calcium chloride Structure Calcium chloride
CAS:10043-52-4
glutaraldehyde Structure glutaraldehyde
CAS:111-30-8
bisphenol A diglycidyl ether Structure bisphenol A diglycidyl ether
CAS:1675-54-3
2-chloroethyl acrylate Structure 2-chloroethyl acrylate
CAS:2206-89-5
tert-Butyl acetoacetate Structure tert-Butyl acetoacetate
CAS:1694-31-1
Dexamethasone Structure Dexamethasone
CAS:50-02-2